MRMD - MariMed: Turnaround MSO July, 26 2021 01:31 PM MariMed Inc MariMed is on pace to easily top $100 million in revenues this year with potential 30% EBITDA margins. The small MSO now has the equity financing to expand the business. The company has limited analyst coverage providing a catalyst for the stock. For further details see: MariMed: Turnaround MSO